COLLABORATIONS
COLLABORATIONS
ICCBBA has an agreement with the European Commission to provide product codes for use in the Tissue Establishments compendium supporting the Single European Code for tissues and cells
ICCBBA is recognized as a UDI issuing agency by FDA (USA), SFDA (Saudi Arabia) and the European Union.
ICCBBA has a Memoranda of Understanding with GMDN, the organization responsible for the Global Medical Device Nomenclature (GMDN) used to identify medical devices.
ICCBBA has collaborated with GS1 since 2007 with a Memorandum of Understanding in place and regularly renewed since then.
ICCBBA is an active participant in the HL7 FHIR Orders and Observations Healthcare Product Group impacting the enhanced Biologically Healthcare Product group impacting the enhanced BiologicallyDerivedProduct resource.
ICCBBA has Memorandums of Understanding with ISBT and WMDA
ICCBBA sits on the ISO US TAG to TC 215 Committee
ICCBBA was approved to join the Joint Initiative Council in December 2022
ICCBBA is one of several Standards Development Organization collaborating within the Standards Coordinating Body network SDOs & Other Organizations Developing Standards - Standards Coordinating Body
The integration of ISBT 128 coding into the USCDI under Biologically Derived Product Interoperability Standards Advisory (ISA) (healthit.gov) has garnered increasing support over the last three years.
ICCBBA has been a member of the Alliance for Regenerative Medicine since 2022 under Foundations, Associations, & Patient Advocates.